We recently demonstrated that perturbation of STAT3 signaling using either RNAi or the STAT3 inhibitor napabucasin re-sensitized treatment-refractory rectal cancer cells to CRT and abolished tumor growth in vivo [22]. This evidence concerns the gene STAT3 and neoplasm.